Related content

Metronomic Therapy for Multi Relapsed/Refractory Lymphoma. A Pilot Study

By  

Current Angiogenesis, Vol. 2, Iss. 2, 2013-09 ,pp. : 119-125

Bentham Science Publishers

Access to resources Recommend Favorite

Rituximab added to an intensified salvage chemotherapy program followed by autologous stem cell transplantation improved the outcome in relapsed and refractory aggressive non-Hodgkin lymphoma

By Sieniawski Michal   Staak Oliver   Glossmann Jan-Peter   Reineke Thorsten   Scheuß Helena   Diehl Volker   Engert Andreas   Josting Andreas  

Annals of Hematology, Vol. 86, Iss. 2, 2007-02 ,pp. : 107-115

Springer Publishing Company

Access to resources Recommend Favorite

Utility of subsequent conventional dose chemotherapy in relapsed/refractory transplant-eligible patients with diffuse large B-cell lymphoma failing platinum-based salvage chemotherapy

By Seshadri T.   Stakiw J.   Pintilie M.   Keating A.   Crump M.   Kuruvilla J.  

Hematology, Vol. 13, Iss. 5, 2008-10 ,pp. : 261-266

Maney Publishing

Access to resources Recommend Favorite

Conditioning with treosulfan and fludarabine for patients with refractory or relapsed nonHodgkin lymphoma

By                            

Molecular and Clinical Oncology, Vol. 2, Iss. 5, 2014-01 ,pp. : 773-782

Spandidos Publications

Access to resources Recommend Favorite

Phase II study of ifosfamide, etoposide, and oxaliplatin (IFETOx) chemotherapy for relapsed or refractory non-Hodgkin’s lymphoma

By Kim Seon-Kyeong   Song Moo-Kon   Chung Joo   Shin Ho-Jin  

International Journal of Hematology, Vol. 98, Iss. 5, 2013-11 ,pp. : 543-548

Springer Publishing Company

Access to resources Recommend Favorite